Methylprednisolone - Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA

Notice type: 3rd Party Publications

Date: 24/08/2017

 

Problem Or Issue:
Important Safety Information communication from Pfizer Healthcare Ireland: New contraindication for injectable methylprednisolone products containing lactose in patients allergic to cow’s milk proteins treated for allergic conditions

Important Safety Information - methylprednisolone
 


« Back